Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Journal of Magnetic Resonance Imaging : JMRI
|
November 3, 2022
Editorial for "Quantification of Prostate Cancer Metabolism Using 3D Multiecho bSSFP and Hyperpolarized [1-<sup>13</sup> C] Pyruvate: Metabolism Differs Between Tumors of the Same Gleason Grade"
Andreas Clemmensen, Mathias Loft, Andreas Kjaer, et al.
Experimental Physiology
|
February 25, 2025
Marie Krogh's contributions to the study of thyroid physiology and pathophysiology
Per Karkov Cramon, Mathias Loft, Ronan M G Berg
Ugeskrift for Laeger
|
May 5, 2024
Mathias Loft, Helle Hjorth Johannesen, Sannia Sjöstedt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 21, 2022
Prospective Phase II Trial of Prognostication by <sup>68</sup>Ga-NOTA-AE105 uPAR PET in Patients with Neuroendocrine Neoplasms: Implications for uPAR-Targeted Therapy
Esben Andreas Carlsen, Mathias Loft, Annika Loft, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 18, 2022
Prospective Phase II Trial of [<sup>68</sup>Ga]Ga-NODAGA-E[c(RGDyK)]<sub>2</sub> PET/CT Imaging of Integrin α<sub>v</sub>β<sub>3</sub> for Prognostication in Patients with Neuroendocrine Neoplasms
Esben Andreas Carlsen, Mathias Loft, Annika Loft, et al.
Diagnostics (Basel, Switzerland)
|
March 6, 2021
Initial Experience with <sup>64</sup>Cu-DOTATATE Digital PET of Patients with Neuroendocrine Neoplasms: Comparison with Analog PET
Mathias Loft, Camilla B Johnbeck, Esben A Carlsen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 3, 2024
Routine Use of [<sup>64</sup>Cu]Cu-DOTATATE PET/CT in a Neuroendocrine Tumor Center: Referral Patterns and Image Results of 2,249 Consecutive Scans
Esben Andreas Carlsen, Mathias Loft, Camilla Bardram Johnbeck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 27, 2021
Semiautomatic Tumor Delineation for Evaluation of <sup>64</sup>Cu-DOTATATE PET/CT in Patients with Neuroendocrine Neoplasms: Prognostication Based on Lowest Lesion Uptake and Total Tumor Volume
Esben Andreas Carlsen, Camilla Bardram Johnbeck, Mathias Loft, et al.
Molecular Imaging and Biology
|
February 15, 2022
Activity Dose Reduction in <sup>64</sup>Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Impact on Image Quality and Lesion Detection Ability
Mathias Loft, Esben A Carlsen, Camilla B Johnbeck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 11, 2023
An Investigation of Lesion Detection Accuracy for Artificial Intelligence-Based Denoising of Low-Dose <sup>64</sup>Cu-DOTATATE PET Imaging in Patients with Neuroendocrine Neoplasms
Mathias Loft, Claes N Ladefoged, Camilla B Johnbeck, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Journal of Magnetic Resonance Imaging : JMRI
|
November 3, 2022
Editorial for "Quantification of Prostate Cancer Metabolism Using 3D Multiecho bSSFP and Hyperpolarized [1-<sup>13</sup> C] Pyruvate: Metabolism Differs Between Tumors of the Same Gleason Grade"
Andreas Clemmensen, Mathias Loft, Andreas Kjaer, et al.
Experimental Physiology
|
February 25, 2025
Marie Krogh's contributions to the study of thyroid physiology and pathophysiology
Per Karkov Cramon, Mathias Loft, Ronan M G Berg
Ugeskrift for Laeger
|
May 5, 2024
Mathias Loft, Helle Hjorth Johannesen, Sannia Sjöstedt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 21, 2022
Prospective Phase II Trial of Prognostication by <sup>68</sup>Ga-NOTA-AE105 uPAR PET in Patients with Neuroendocrine Neoplasms: Implications for uPAR-Targeted Therapy
Esben Andreas Carlsen, Mathias Loft, Annika Loft, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 18, 2022
Prospective Phase II Trial of [<sup>68</sup>Ga]Ga-NODAGA-E[c(RGDyK)]<sub>2</sub> PET/CT Imaging of Integrin α<sub>v</sub>β<sub>3</sub> for Prognostication in Patients with Neuroendocrine Neoplasms
Esben Andreas Carlsen, Mathias Loft, Annika Loft, et al.
Diagnostics (Basel, Switzerland)
|
March 6, 2021
Initial Experience with <sup>64</sup>Cu-DOTATATE Digital PET of Patients with Neuroendocrine Neoplasms: Comparison with Analog PET
Mathias Loft, Camilla B Johnbeck, Esben A Carlsen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 3, 2024
Routine Use of [<sup>64</sup>Cu]Cu-DOTATATE PET/CT in a Neuroendocrine Tumor Center: Referral Patterns and Image Results of 2,249 Consecutive Scans
Esben Andreas Carlsen, Mathias Loft, Camilla Bardram Johnbeck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 27, 2021
Semiautomatic Tumor Delineation for Evaluation of <sup>64</sup>Cu-DOTATATE PET/CT in Patients with Neuroendocrine Neoplasms: Prognostication Based on Lowest Lesion Uptake and Total Tumor Volume
Esben Andreas Carlsen, Camilla Bardram Johnbeck, Mathias Loft, et al.
Molecular Imaging and Biology
|
February 15, 2022
Activity Dose Reduction in <sup>64</sup>Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Impact on Image Quality and Lesion Detection Ability
Mathias Loft, Esben A Carlsen, Camilla B Johnbeck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 11, 2023
An Investigation of Lesion Detection Accuracy for Artificial Intelligence-Based Denoising of Low-Dose <sup>64</sup>Cu-DOTATATE PET Imaging in Patients with Neuroendocrine Neoplasms
Mathias Loft, Claes N Ladefoged, Camilla B Johnbeck, et al.
Page
of 2